P70S6K 1 regulation of angiogenesis through VEGF and HIF-1α expression

被引:73
作者
Bian, Chuan-Xiu [2 ]
Shi, Zhumei [2 ]
Meng, Qiao [1 ]
Jiang, Yue [1 ]
Liu, Ling-Zhi [1 ]
Jiang, Bing-Hua [1 ,2 ]
机构
[1] Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA
[2] Nanjing Med Univ, Ctr Canc, Dept Pathol, Nanjing 210029, Peoples R China
基金
中国国家自然科学基金;
关键词
p70S6K1; VEGF; HIF-1; Tumor angiogenesis; siRNA; ENDOTHELIAL GROWTH-FACTOR; PHOSPHATIDYLINOSITOL; 3-KINASE; MAMMALIAN TARGET; OVARIAN-CANCER; SIGNALING PATHWAY; KINASE-ACTIVITY; MTOR; RAPAMYCIN; CELLS; TRANSLATION;
D O I
10.1016/j.bbrc.2010.06.080
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The 70 kDa ribosomal S6 kinase 1 (p70S6K1), a downstream target of phosphoinositide 3-kinase (PI3K) and ERK mitogen-activated protein kinase (MAPK), is an important regulator of cell cycle progression, and cell proliferation. Recent studies indicated an important role of p70S6K1 in PTEN-negative and AKT-overexpressing tumors. However, the mechanism of p70S6K1 in tumor angiogenesis remains to be elucidated. In this study, we specifically inhibited p70S6K1 activity in ovarian cancer cells using vector-based small interfering RNA (siRNA) against p70S6K1. We found that knockdown of p70S6K1 significantly decreased VEGF protein expression and VEGF transcriptional activation through the HIF-1 alpha binding site at its enhancer region. The expression of p70S6K1 siRNA specifically inhibited but HIF-1 alpha, but not HIF-1 beta protein expression. We also found that p70S6K1 down-regulation inhibited ovarian tumor growth and angiogenesis, and decreased cell proliferation and levels of VEGF and HIF-1 alpha expression in tumor tissues. Our results suggest that p70S6K1 is required for tumor growth and angiogenesis through HIF-1 alpha and VEGF expression, providing a molecular mechanism of human ovarian cancer mediated by p70S6K1 signaling. (C) 2010 Elsevier Inc. All rights reserved.
引用
收藏
页码:395 / 399
页数:5
相关论文
共 34 条
[11]   INDUCTION OF ANGIOGENESIS DURING THE TRANSITION FROM HYPERPLASIA TO NEOPLASIA [J].
FOLKMAN, J ;
WATSON, K ;
INGBER, D ;
HANAHAN, D .
NATURE, 1989, 339 (6219) :58-61
[12]   WHAT IS THE EVIDENCE THAT TUMORS ARE ANGIOGENESIS DEPENDENT [J].
FOLKMAN, J .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1990, 82 (01) :4-6
[13]  
Forsythe JA, 1996, MOL CELL BIOL, V16, P4604
[14]   In vivo antitumor effects of the mTOR inhibitor CCI-779 against human multiple myeloma cells in a xenograft model [J].
Frost, P ;
Moatamed, F ;
Bai, H ;
Shi, YJ ;
Gera, J ;
Yan, HJ ;
Frost, P ;
Gibbons, J ;
Lichtenstein, A .
BLOOD, 2004, 104 (13) :4181-4187
[15]   Insulin-like growth factor 1 induces hypoxia-inducible factor 1-mediated vascular endothelial growth factor expression, which is dependent on MAP kinase and phosphatidylinositol 3-kinase signaling in colon cancer cells [J].
Fukuda, R ;
Hirota, K ;
Fan, F ;
Do Jung, Y ;
Ellis, LM ;
Semenza, GL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (41) :38205-38211
[16]   Inhibitors of the PI3K/Akt/mTOR Pathway: New Hope for Breast Cancer Patients [J].
Ghayad, Sandra E. ;
Cohen, Pascale A. .
RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY, 2010, 5 (01) :29-57
[17]   Isolation and purification of vascular endothelial growth factor (VEGF) from ascitic fluid of ovarian cancer patients [J].
Ghosh, S ;
Maity, P .
PATHOLOGY & ONCOLOGY RESEARCH, 2004, 10 (02) :104-108
[18]   Angiogenesis as a potential target of pharmaconutrients in cancer therapy [J].
Granci, Virginie ;
Dupertuis, Yves M. ;
Pichard, Claude .
CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE, 2010, 13 (04) :417-422
[19]   Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor [J].
Guba, M ;
von Breitenbuch, P ;
Steinbauer, M ;
Koehl, G ;
Flegel, S ;
Hornung, M ;
Bruns, CJ ;
Zuelke, C ;
Farkas, S ;
Anthuber, M ;
Jauch, KW ;
Geissler, EK .
NATURE MEDICINE, 2002, 8 (02) :128-135
[20]   Regulation of hypoxia-inducible factor 1α expression and function by the mammalian target of rapamycin [J].
Hudson, CC ;
Liu, M ;
Chiang, GG ;
Otterness, DM ;
Loomis, DC ;
Kaper, F ;
Giaccia, AJ ;
Abraham, RT .
MOLECULAR AND CELLULAR BIOLOGY, 2002, 22 (20) :7004-7014